Eric Pauwels, CHIEF BUSINESS OFFICER at PTC THERAPEUTICS, INC. (PTCT), sold 38,813 shares at $78.33 ($3.0M) on 2025-12-19, disclosed to the SEC on 2025-12-23.
Scheduled sale ($3.0M) by CHIEF BUSINESS OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.45 | 193 | $15K | 0.5% |
| 2 | $75.66 | 37 | $3K | 0.1% |
| 3 | $75.77 | 1,500 | $114K | 3.8% |
| 4 | $76.33 | 4,537 | $346K | 11.5% |
| 5 | $76.33 | 4,537 | $346K | 11.5% |
| 6 | $77.26 | 42 |
| $3K |
| 0.1% |
| 7 | $77.55 | 10,548 | $818K | 27.3% |
| 8 | $77.55 | 10,548 | $818K | 27.3% |
| 9 | $77.73 | 313 | $24K | 0.8% |
| 10 | $78.01 | 59 | $5K | 0.2% |
| 11 | $78.33 | 3,220 | $252K | 8.4% |
| 12 | $78.33 | 3,220 | $252K | 8.4% |
| 13 | $78.43 | 59 | $5K | 0.2% |
| Total | $77.32 avg | 38,813 | $3.0M | 100% |
| Filing → |
| PTCT | SELL | 2026-01-12 | $566K | — | Filing → |
| PTCT | SELL | 2026-01-08 | $242K | — | Filing → |
| PTCT | SELL | 2025-12-19 | $6.5M | — | Filing → |